- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0783 - Cellules TCellules NKProgéniteurs de cellules T ou NK
Détention brevets de la classe C12N 5/0783
Brevets de cette classe: 10966
Historique des publications depuis 10 ans
|
443
|
593
|
776
|
1018
|
1152
|
1200
|
1332
|
1217
|
1233
|
553
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1152 |
684 |
| Iovance Biotherapeutics, Inc. | 336 |
245 |
| The Regents of the University of California | 19784 |
218 |
| The Trustees of the University of Pennsylvania | 4295 |
196 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
148 |
| Board of Regents, The University of Texas System | 5738 |
136 |
| Cellectis | 404 |
128 |
| Juno Therapeutics, Inc. | 382 |
111 |
| Memorial Sloan-Kettering Cancer Center | 1901 |
103 |
| Baylor College of Medicine | 936 |
102 |
| Novartis AG | 10963 |
94 |
| The Board of Trustees of the Leland Stanford Junior University | 6329 |
94 |
| Autolus Limited | 251 |
81 |
| City of Hope | 977 |
81 |
| Immunitybio, Inc. | 368 |
75 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 922 |
72 |
| Regents of the University of Minnesota | 2684 |
71 |
| Kite Pharma, Inc. | 405 |
70 |
| FATE Therapeutics, Inc. | 198 |
67 |
| Kyoto University | 2785 |
62 |
| Autres propriétaires | 8128 |